Top Tweets for #StandardEngineeringTechnology
SuperStocks of June month with Liquidity
#RamcoSystems – 87.01%
#StandardEngineeringTechnology – 84.26%
#PrakashPipes – 67.83%
#MSTC – 59.67%
#ParasDefence – 58.26%
#ShreeRefrigerator – 55.79%
#CarTradeTech – 51.97%
#AegisLogistics – 51.62%
#TeamTechFormwork – 51.33%
#StandardEngineering #StandardEngineeringTechnology #SETL #GScale
Standard Engineering Technology Limited
For a decade, Standard Engineering Technology built leak-proof, high-pressure liquid systems for pharma factories — the kind where a single failure ruins a drug batch.
In June 2026, management asked a sharp question: if we can pipe corrosive chemicals without a single leak, can we pipe coolant around a $40,000 GPU without one too?
They answered it by buying 51% of GScale Energy for ₹190 Crore — instantly entering AI data center liquid cooling.
But here's the catch: 49% of GScale's profit legally belongs to someone else. So how does this actually move SETL's bottom line?
🧵 Thread ↓
Business story
The story starts in 2012 in Hyderabad as Standard Glass Lining Technology — manufacturing corrosion-resistant glass-lined reactors for pharma giants like Dr. Reddy's, Laurus Labs, and Hetero.
First pivot: from selling individual parts to becoming a turnkey engineering platform — owning process design, automation, and full plant deployment. Single-point accountability. This is what took revenue from ₹614Cr (FY25) to ₹793Cr (FY26).
Second pivot — the bold one: applying that exact zero-leak fluid engineering DNA to AI servers. NVIDIA Blackwell chips generate over 100kW per rack — too hot for fans, requiring liquid cooling skids and Coolant Distribution Units (CDUs).
SETL didn't build this tech division from scratch. They bought it — acquiring GScale Energy, led by Kasu Brahma Reddy, the former President of CtrlS Datacenters who personally oversaw 486 MW of data center builds. Instant credibility, instant pipeline access.
This is the rare pivot where the old business literally manufactures the new one's core competency.
Moat —
The legacy pharma business: Strong moat. 2-4 years to win vendor approval from top API players, >90% client retention.
The new data center business: Moderate moat, still being built. Three real edges —
① Vendor qualification lock — hyperscalers take 12-24 months to validate a cooling vendor, and the approval is tied to a specific factory. Completely non-transferable.
② Shared tooling advantage — SETL applies decade-old precision fabrication facilities to cooling skids, meaning lower R&D and tooling cost than a generic competitor starting cold.
③ Structural switching cost — a malfunctioning cooling skid can ruin millions in server hardware. Operators don't swap vendors lightly.
What's missing: no patents, the moat is process know-how. And critically — the tech moat is still unproven at scale. It depends on execution, not yet a track record.
Valuation & the minority interest math
Here's where the hook question gets answered — exactly how the acquisition flows to the bottom line.
FY26 A: Rev ₹793Cr | EBITDA 17.4% | Consol. PAT ₹83Cr | EPS ₹4.01
FY27 E: Rev ₹1,120Cr | EBITDA 20.0% | Consol. PAT ₹139Cr | Owner PAT ₹116Cr | EPS ₹5.50
FY28 E: Rev ₹1,550Cr | EBITDA 24.0% | Consol. PAT ₹244Cr | Owner PAT ₹171Cr | EPS ₹8.13
Notice the gap: Consolidated PAT and shareholder-owned PAT diverge sharply from FY27 onward. That's because under Ind AS 110, SETL must show 100% of GScale's revenue and EBITDA on its books — but only 51% of the profit. The other 49% legally leaks out as Non-Controlling Interest.
So EPS growth (₹4.01 → ₹8.13, 2x in two years) is real, but slower than the headline revenue growth (₹793Cr → ₹1,550Cr, also ~2x) would suggest at first glance — minority interest is the tax for not owning 100%.
Is there big operational leverage? Yes, genuinely. EBITDA margin expands from 17.4% to 24% as the high-margin tech division scales — absolute EBITDA nearly triples (₹138Cr → ₹372Cr) while revenue only doubles.
Growth triggers:
✅ ₹250Cr data center revenue target for FY27 from GScale's existing LOIs
✅ Production live from November 2026, scaling 35%→70% utilization by late FY28
✅ Interest coverage >75x by FY28 — zero debt drag, fully self-funded
✅ ROIC jumps from 14.7% (FY26) to 25.4% (FY28E)
Red flags:
⚠ Any slippage past Nov 2026 production launch compresses FY27 numbers directly
⚠ Tech segment currently <1% market share — pre-production phase, unproven at scale
Management quality & governance
Two-leadership structure, both domain-credible.
Nageshwar Rao (MD) — over a decade building the pharma GLR business, the long-term client relationships with Dr. Reddy's and Laurus Labs are his.
Kasu Brahma Reddy (Head, Data Center Division) — former President of CtrlS Datacenters, personally executed 486 MW of data center infrastructure before joining.
68.4% promoter holding, zero pledged shares. The ₹190Cr GScale deal was funded ₹125Cr from internal cash flows plus a share-swap — no debt taken. Track record: management promised the turnkey platform shift, delivered it (₹614Cr→₹793Cr revenue). Promised a November 2026 production launch for GScale, and facility expansion to 10 lakh sq ft is on schedule.
Governance flags:
⚠ Minor pre-IPO fixed-asset restatements during corporate restructuring — requires ongoing monitoring ⚠ The entire tech pivot's credibility rests heavily on one person — Kasu Brahma Reddy's personal hyperscaler relationships. Institutionalizing this into account management is the real test
⚠ GScale's 49% minority promoters retain independent equity — alignment is good for execution, but introduces future governance complexity on cash flow distribution between parent and subsidiary
Order pipeline — does it justify the growth?
On the legacy side, the answer is simple: ₹793Cr firm order book, built on relationships averaging years with top-tier pharma clients. That part is not in question.
On the GScale side, it's earlier-stage and conviction-dependent.
What exists today: GScale's existing Letters of Intent (LOIs) with data center operators, built on Kasu Brahma Reddy's CtrlS-era relationships. Management has set a specific, falsifiable target — ₹250Cr of data center revenue within the first months of FY27 consolidated operations.
What's not yet proven: whether LOIs convert into binding orders at the pace assumed, whether the November 2026 production launch holds, and whether utilization actually scales from 35% in FY27 to 70% by late FY28 as modeled.
The India liquid cooling TAM itself is compounding at 32-35% CAGR (₹2,200Cr → ₹9,200Cr by 2030) — the demand wave is real and external to SETL's execution. The risk is entirely about SETL/GScale capturing their slice of it on time.
Watch the FY27 Q3/Q4 print closely — that's the first real test of whether the ₹250Cr target and the November production launch both hold.
Closing thesis
So how does leveraging pharma precision into a 51% DC cooling stake actually move the bottom line?
The straight answer — favorably, but with a discount. The 49% minority interest means shareholders don't get the full benefit of the tech division's explosive growth; EPS still roughly doubles by FY28 (₹4.01 → ₹8.13), but it would have grown faster at 100% ownership.
What makes this credible rather than speculative: SETL isn't entering a market it doesn't understand. The exact engineering skill — zero-leak, high-pressure liquid transfer near sensitive, high-value equipment — transfers almost directly from pharma reactors to GPU cooling skids. That's a rare, genuine technical synergy, not a diworsification.
Triggers to watch:
✅ November 2026 — GScale production goes live on schedule
✅ FY27 ₹250Cr data center revenue target — first real proof point
✅ Utilization climbing from 35% toward 70% through FY28
✅ EBITDA margin crossing 20% — confirms the high-margin tech mix is working
⚠ Any LOI-to-order conversion delays from hyperscaler clients
⚠ Over-dependence on Kasu Brahma Reddy's personal network without institutional transfer
[Not investment Advice, DYOR]
[Not SEBI Registered Analysis, Modelling with simple projections with publicly available data]
![ramesh_vd's tweet photo. #StandardEngineering #StandardEngineeringTechnology #SETL #GScale
Standard Engineering Technology Limited
For a decade, Standard Engineering Technology built leak-proof, high-pressure liquid systems for pharma factories — the kind where a single failure ruins a drug batch.
In June 2026, management asked a sharp question: if we can pipe corrosive chemicals without a single leak, can we pipe coolant around a $40,000 GPU without one too?
They answered it by buying 51% of GScale Energy for ₹190 Crore — instantly entering AI data center liquid cooling.
But here's the catch: 49% of GScale's profit legally belongs to someone else. So how does this actually move SETL's bottom line?
🧵 Thread ↓
Business story
The story starts in 2012 in Hyderabad as Standard Glass Lining Technology — manufacturing corrosion-resistant glass-lined reactors for pharma giants like Dr. Reddy's, Laurus Labs, and Hetero.
First pivot: from selling individual parts to becoming a turnkey engineering platform — owning process design, automation, and full plant deployment. Single-point accountability. This is what took revenue from ₹614Cr (FY25) to ₹793Cr (FY26).
Second pivot — the bold one: applying that exact zero-leak fluid engineering DNA to AI servers. NVIDIA Blackwell chips generate over 100kW per rack — too hot for fans, requiring liquid cooling skids and Coolant Distribution Units (CDUs).
SETL didn't build this tech division from scratch. They bought it — acquiring GScale Energy, led by Kasu Brahma Reddy, the former President of CtrlS Datacenters who personally oversaw 486 MW of data center builds. Instant credibility, instant pipeline access.
This is the rare pivot where the old business literally manufactures the new one's core competency.
Moat —
The legacy pharma business: Strong moat. 2-4 years to win vendor approval from top API players, >90% client retention.
The new data center business: Moderate moat, still being built. Three real edges —
① Vendor qualification lock — hyperscalers take 12-24 months to validate a cooling vendor, and the approval is tied to a specific factory. Completely non-transferable.
② Shared tooling advantage — SETL applies decade-old precision fabrication facilities to cooling skids, meaning lower R&D and tooling cost than a generic competitor starting cold.
③ Structural switching cost — a malfunctioning cooling skid can ruin millions in server hardware. Operators don't swap vendors lightly.
What's missing: no patents, the moat is process know-how. And critically — the tech moat is still unproven at scale. It depends on execution, not yet a track record.
Valuation & the minority interest math
Here's where the hook question gets answered — exactly how the acquisition flows to the bottom line.
FY26 A: Rev ₹793Cr | EBITDA 17.4% | Consol. PAT ₹83Cr | EPS ₹4.01
FY27 E: Rev ₹1,120Cr | EBITDA 20.0% | Consol. PAT ₹139Cr | Owner PAT ₹116Cr | EPS ₹5.50
FY28 E: Rev ₹1,550Cr | EBITDA 24.0% | Consol. PAT ₹244Cr | Owner PAT ₹171Cr | EPS ₹8.13
Notice the gap: Consolidated PAT and shareholder-owned PAT diverge sharply from FY27 onward. That's because under Ind AS 110, SETL must show 100% of GScale's revenue and EBITDA on its books — but only 51% of the profit. The other 49% legally leaks out as Non-Controlling Interest.
So EPS growth (₹4.01 → ₹8.13, 2x in two years) is real, but slower than the headline revenue growth (₹793Cr → ₹1,550Cr, also ~2x) would suggest at first glance — minority interest is the tax for not owning 100%.
Is there big operational leverage? Yes, genuinely. EBITDA margin expands from 17.4% to 24% as the high-margin tech division scales — absolute EBITDA nearly triples (₹138Cr → ₹372Cr) while revenue only doubles.
Growth triggers:
✅ ₹250Cr data center revenue target for FY27 from GScale's existing LOIs
✅ Production live from November 2026, scaling 35%→70% utilization by late FY28
✅ Interest coverage >75x by FY28 — zero debt drag, fully self-funded
✅ ROIC jumps from 14.7% (FY26) to 25.4% (FY28E)
Red flags:
⚠ Any slippage past Nov 2026 production launch compresses FY27 numbers directly
⚠ Tech segment currently <1% market share — pre-production phase, unproven at scale
Management quality & governance
Two-leadership structure, both domain-credible.
Nageshwar Rao (MD) — over a decade building the pharma GLR business, the long-term client relationships with Dr. Reddy's and Laurus Labs are his.
Kasu Brahma Reddy (Head, Data Center Division) — former President of CtrlS Datacenters, personally executed 486 MW of data center infrastructure before joining.
68.4% promoter holding, zero pledged shares. The ₹190Cr GScale deal was funded ₹125Cr from internal cash flows plus a share-swap — no debt taken. Track record: management promised the turnkey platform shift, delivered it (₹614Cr→₹793Cr revenue). Promised a November 2026 production launch for GScale, and facility expansion to 10 lakh sq ft is on schedule.
Governance flags:
⚠ Minor pre-IPO fixed-asset restatements during corporate restructuring — requires ongoing monitoring ⚠ The entire tech pivot's credibility rests heavily on one person — Kasu Brahma Reddy's personal hyperscaler relationships. Institutionalizing this into account management is the real test
⚠ GScale's 49% minority promoters retain independent equity — alignment is good for execution, but introduces future governance complexity on cash flow distribution between parent and subsidiary
Order pipeline — does it justify the growth?
On the legacy side, the answer is simple: ₹793Cr firm order book, built on relationships averaging years with top-tier pharma clients. That part is not in question.
On the GScale side, it's earlier-stage and conviction-dependent.
What exists today: GScale's existing Letters of Intent (LOIs) with data center operators, built on Kasu Brahma Reddy's CtrlS-era relationships. Management has set a specific, falsifiable target — ₹250Cr of data center revenue within the first months of FY27 consolidated operations.
What's not yet proven: whether LOIs convert into binding orders at the pace assumed, whether the November 2026 production launch holds, and whether utilization actually scales from 35% in FY27 to 70% by late FY28 as modeled.
The India liquid cooling TAM itself is compounding at 32-35% CAGR (₹2,200Cr → ₹9,200Cr by 2030) — the demand wave is real and external to SETL's execution. The risk is entirely about SETL/GScale capturing their slice of it on time.
Watch the FY27 Q3/Q4 print closely — that's the first real test of whether the ₹250Cr target and the November production launch both hold.
Closing thesis
So how does leveraging pharma precision into a 51% DC cooling stake actually move the bottom line?
The straight answer — favorably, but with a discount. The 49% minority interest means shareholders don't get the full benefit of the tech division's explosive growth; EPS still roughly doubles by FY28 (₹4.01 → ₹8.13), but it would have grown faster at 100% ownership.
What makes this credible rather than speculative: SETL isn't entering a market it doesn't understand. The exact engineering skill — zero-leak, high-pressure liquid transfer near sensitive, high-value equipment — transfers almost directly from pharma reactors to GPU cooling skids. That's a rare, genuine technical synergy, not a diworsification.
Triggers to watch:
✅ November 2026 — GScale production goes live on schedule
✅ FY27 ₹250Cr data center revenue target — first real proof point
✅ Utilization climbing from 35% toward 70% through FY28
✅ EBITDA margin crossing 20% — confirms the high-margin tech mix is working
⚠ Any LOI-to-order conversion delays from hyperscaler clients
⚠ Over-dependence on Kasu Brahma Reddy's personal network without institutional transfer
[Not investment Advice, DYOR]
[Not SEBI Registered Analysis, Modelling with simple projections with publicly available data]](https://pbs.twimg.com/media/HMEFyYtW0AAEjXc.png)
📈 FY26 was their best year ever. Management says FY27 could be even better. 🔥
#StandardEngineeringTechnology
From equipment supplier ➜ Integrated engineering platform.
That's the biggest takeaway from the Q4FY26 concall.
Highlights:
🔹 FY26 was the best year in company history
🔹 FY27 expected to be even stronger
🔹 Quarterly revenue target: ₹250–300 Cr
🔹 ₹130 Cr greenfield expansion underway
🔹 Entering Oil & Gas, Nuclear, Aerospace & Defence
🔹 Heat exchanger orders rising strongly
🔹 Order book remains healthy
🔹 EBITDA margins expected to improve
🔹 Working capital cycle improved
🔹 Positive operational cash generation
Management is positioning the company as a one-stop engineering solutions provider rather than just an equipment manufacturer.
If execution remains strong, this could be an interesting engineering story to track over the next few years.
Not a buy/sell call.
#Q4FY26 #SETL #Engineering #StocksToWatch #IndianStockMarket
Last Seen Hashtags on Sotwe
Teenage video*
Seen from Netherlands
dentro
Seen from Switzerland
nolimit filter:native_video
Seen from Turkey
ميقا_حصريات
Seen from Turkey
Ödemişpasif
Seen from Netherlands
crackwhore
Seen from United States
市ノ瀬沙耶香
Seen from Germany
roughfuck
Seen from Turkey
dickflash
Seen from Turkey
adultevent
Seen from Netherlands
Most Popular Users
Elon Musk 
@elonmusk
240.7M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
110.8M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
90.9M followers
KATY PERRY
@katyperry
87.8M followers
Taylor Swift
@taylorswift13
81.6M followers
Lady Gaga
@ladygaga
73.2M followers
Virat Kohli
@imvkohli
70.1M followers
Kim Kardashian
@kimkardashian
69.8M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
62.9M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
60.9M followers
X
@x
60.8M followers